MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (Q53341906)
Jump to navigation
Jump to search
scientific article published in September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. |
scientific article published in September 2006 |
Statements
MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. (English)
Naoki Ohmiya
Nobuyuki Mabuchi
Akihiro Itoh
Yoshiki Hirooka
Yasumasa Niwa
Hidemi Goto
1 September 2006
24
27
4434-4440